Schweiger Dermatology, P.C. /ID# 255336

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis

Closed trials

• Completed

  Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

  NCT05969223· Phase 4· AbbVie· Source